To view the PDF file, sign up for a MySharenet subscription.

MDC - Mediclinic International Limited - Dealings in securities by directors of

Release Date: 08/06/2012 08:54
Code(s): MDC
Wrap Text

MDC - Mediclinic International Limited - Dealings in securities by directors of the company and of major subsidiaries in terms of The Mediclinic management incentive scheme Mediclinic International Limited Incorporated in the Republic of South Africa Reg. no. 1983/010725/06 Income tax no: 9950122714 Share code: MDC ISIN code: ZAE000074142 ("Mediclinic" or "the Company") DEALINGS IN SECURITIES BY DIRECTORS OF THE COMPANY AND OF MAJOR SUBSIDIARIES IN TERMS OF THE MEDICLINIC MANAGEMENT INCENTIVE SCHEME In compliance with the JSE Limited Listings Requirements, shareholders are advised that the following directors received Mediclinic shares on 6 June 2012 in terms of the Mediclinic Management Incentive Scheme: Directors of Mediclinic Number of Value of Nature of director`s securities transaction interest E de la H Hertzog 21 495 R780 891.86 Indirect beneficial (Wieres Trust) D P Meintjes 18 671 R678 298.76 Direct beneficial C I Tingle 15 623 R567 567.97 Direct beneficial C A van der Merwe 7 468 R271 304.97 Direct beneficial K H S Pretorius 12 449 R452 259.72 Direct beneficial G C Hattingh (Company 6 295 R228 691.06 Indirect beneficial Secretary) (Ghwarriebos Trust) Directors of major Company Number of Value of Nature of subsidiaries securities transaction director`s interest
W H Aucamp Mediclinic 8 588 R311 993.45 Direct Southern Africa beneficial Limited A J Joubert Mediclinic 9 431 R342 618.80 Direct Southern Africa beneficial Limited N S Matlala Mediclinic 8 274 R300 586.15 Direct Southern Africa beneficial
Limited B Valodia Mediclinic 8 354 R303 492.47 Direct Southern Africa beneficial Limited
T A Lockyer Mediclinic 565 R20 525.89 Direct (Company Southern Africa beneficial Secretary) Limited L Heerink-Smit Mediclinic 529 R19 218.04 Direct (Company Investments beneficial Secretary) Limited The shares were acquired at R36.329 per share, being the 30 day volume weighted average price of Mediclinic`s shares on the JSE for the period ending on 31 March 2012, as prescribed by the Mediclinic Management Incentive Scheme. Clearance for the above on market transactions was obtained as required by the JSE Listings Requirements. Stellenbosch 8 June 2012 Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa PO Box 456, Stellenbosch 7599, South Africa Tel +27 (0)21 809 6500 Fax +27 (0)21 886 4037 Ethics Line: 0800 005 316 Website: www.mediclinic.com Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 08/06/2012 08:54:02 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Share This Story